Colorectal Cancer Clinical Trials in Detroit

Showing 281-300 of 331 trials

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

NCT00441337

To evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer, malignant melanoma, clear cell renal cell cancer or hormone refractory prostate cancer

Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more

Bristol-Myers Squibb39 participantsStarted Aug 2006

Baltimore, Maryland, United States • Detroit, Michigan, United States • St Louis, Missouri, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

NCT01105377

This phase II trial is studying how well giving azacitidine together with entinostat works in treating patients with metastatic colorectal cancer. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Entinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving azacitidine together with entinostat may kill more tumor cells.

Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more

National Cancer Institute (NCI)47 participantsStarted Apr 2010

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +11 more locations

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy

Other Conditions in Detroit